ID

17547

Descripción

Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C; ODM derived from: https://clinicaltrials.gov/show/NCT00148863

Link

https://clinicaltrials.gov/show/NCT00148863

Palabras clave

  1. 22/9/16 22/9/16 -
Subido en

22 de septiembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hepatitis C, Chronic NCT00148863

Eligibility Hepatitis C, Chronic NCT00148863

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
positive anti-hcv antibodies
Descripción

Hepatitis C Antibodies Positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0166049
UMLS CUI [1,2]
C1514241
positive hcv rna (quantitative method)
Descripción

HCV viral load Positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1868902
UMLS CUI [1,2]
C1514241
previous treatment with peg-interferon alpha 2b 1.0 to 1.5 micro g/kg (during at least 12 weeks) with ribavirin (at least 800 mg/day during at least 12 weeks),stopped since at least 3 months
Descripción

peginterferon alfa-2b Prior Therapy ended | Ribavirin Prior Therapy ended

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0796545
UMLS CUI [1,2]
C1514463
UMLS CUI [1,3]
C2746065
UMLS CUI [2,1]
C0035525
UMLS CUI [2,2]
C1514463
UMLS CUI [2,3]
C2746065
without lower dosage during previous treatment
Descripción

peginterferon alfa-2b Prior Therapy Dosage | Ribavirin Prior Therapy Dosage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0796545
UMLS CUI [1,2]
C1514463
UMLS CUI [1,3]
C0178602
UMLS CUI [2,1]
C0035525
UMLS CUI [2,2]
C1514463
UMLS CUI [2,3]
C0178602
non responder to the previous treatment with peg-interferon alpha 2b and ribavirin, with detectable hcv rna at w24 or decrease of less than 2 log10 copies/ml at w12 or decrease greater than 2 log10 but detectable hcv rna
Descripción

peginterferon alfa-2b Unresponsive to Treatment | Ribavirin Unresponsive to Treatment | HCV viral load Detectable | HCV viral load Decrease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0796545
UMLS CUI [1,2]
C0205269
UMLS CUI [2,1]
C0035525
UMLS CUI [2,2]
C0205269
UMLS CUI [3,1]
C1868902
UMLS CUI [3,2]
C3830527
UMLS CUI [4,1]
C1868902
UMLS CUI [4,2]
C0547047
metavir over f2 on the most recent biopsy
Descripción

Metavir score | Biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3888527
UMLS CUI [2]
C0005558
alt increase over normal value twice during last 6 months
Descripción

Alanine aminotransferase increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151905
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
hiv infection
Descripción

HIV Infections

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019693
psychiatric pathology
Descripción

Mental disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004936
alcool consummation
Descripción

Alcohol consumption

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001948
cirrhosis
Descripción

Liver Cirrhosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023890
pregnancy or plan of pregnancy
Descripción

Pregnancy | Pregnancy, Planned

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
breastfeeding
Descripción

Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147

Similar models

Eligibility Hepatitis C, Chronic NCT00148863

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Hepatitis C Antibodies Positive
Item
positive anti-hcv antibodies
boolean
C0166049 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
HCV viral load Positive
Item
positive hcv rna (quantitative method)
boolean
C1868902 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
peginterferon alfa-2b Prior Therapy ended | Ribavirin Prior Therapy ended
Item
previous treatment with peg-interferon alpha 2b 1.0 to 1.5 micro g/kg (during at least 12 weeks) with ribavirin (at least 800 mg/day during at least 12 weeks),stopped since at least 3 months
boolean
C0796545 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C2746065 (UMLS CUI [1,3])
C0035525 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
C2746065 (UMLS CUI [2,3])
peginterferon alfa-2b Prior Therapy Dosage | Ribavirin Prior Therapy Dosage
Item
without lower dosage during previous treatment
boolean
C0796545 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0035525 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
peginterferon alfa-2b Unresponsive to Treatment | Ribavirin Unresponsive to Treatment | HCV viral load Detectable | HCV viral load Decrease
Item
non responder to the previous treatment with peg-interferon alpha 2b and ribavirin, with detectable hcv rna at w24 or decrease of less than 2 log10 copies/ml at w12 or decrease greater than 2 log10 but detectable hcv rna
boolean
C0796545 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
C0035525 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C1868902 (UMLS CUI [3,1])
C3830527 (UMLS CUI [3,2])
C1868902 (UMLS CUI [4,1])
C0547047 (UMLS CUI [4,2])
Metavir score | Biopsy
Item
metavir over f2 on the most recent biopsy
boolean
C3888527 (UMLS CUI [1])
C0005558 (UMLS CUI [2])
Alanine aminotransferase increased
Item
alt increase over normal value twice during last 6 months
boolean
C0151905 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
HIV Infections
Item
hiv infection
boolean
C0019693 (UMLS CUI [1])
Mental disorders
Item
psychiatric pathology
boolean
C0004936 (UMLS CUI [1])
Alcohol consumption
Item
alcool consummation
boolean
C0001948 (UMLS CUI [1])
Liver Cirrhosis
Item
cirrhosis
boolean
C0023890 (UMLS CUI [1])
Pregnancy | Pregnancy, Planned
Item
pregnancy or plan of pregnancy
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Breast Feeding
Item
breastfeeding
boolean
C0006147 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial